Windlas Biotech Limited (WINDLAS) — Capital Reinvestment Ratio
Windlas Biotech Limited (WINDLAS) has a Capital Reinvestment Ratio of 0.77x as of March 2025, meaning it reinvests 1% of its operating cash flow (Rs681.87 Million) in capital expenditures (Rs521.94 Million). See Windlas Biotech Limited net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Windlas Biotech Limited Capital Reinvestment Ratio (2018–2025)
This chart tracks Windlas Biotech Limited's Capital Reinvestment Ratio across 8 annual periods. Check cash flow reinvestment rate of Windlas Biotech Limited to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Windlas Biotech Limited (2018–2025)
Year-by-year Capital Reinvestment Ratio for Windlas Biotech Limited from 2018 to 2025. For live market cap and broader valuation context, see Windlas Biotech Limited (WINDLAS) total market value.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.77x | Rs681.87 Million | Rs521.94 Million | ▲ +121.3% |
| 2024 | 0.35x | Rs1.09 Billion | Rs376.84 Million | ▼ -70.3% |
| 2023 | 1.16x | Rs609.65 Million | Rs708.90 Million | ▼ -28.3% |
| 2022 | 1.62x | Rs91.30 Million | Rs148.04 Million | ▲ +217.6% |
| 2021 | 0.51x | Rs114.54 Million | Rs58.47 Million | ▼ -16.6% |
| 2020 | 0.61x | Rs250.06 Million | Rs153.10 Million | ▲ +27.6% |
| 2019 | 0.48x | Rs186.54 Million | Rs89.54 Million | ▼ -44.9% |
| 2018 | 0.87x | Rs295.91 Million | Rs257.82 Million | — |